Literature DB >> 11022033

Localization of sequences within the C-terminal domain of the cystic fibrosis transmembrane conductance regulator which impact maturation and stability.

M Gentzsch1, J R Riordan.   

Abstract

Some disease-associated truncations within the 100-residue domain C-terminal of the second nucleotide-binding domain destabilize the mature protein (Haardt, M., Benharouga, M., Lechardeur, D., Kartner, N., and Lukacs, G. L. (1999) J. Biol. Chem. 274, 21873-21877). We now have identified three short oligopeptide regions in the C-terminal domain which impact cystic fibrosis transmembrane conductance regulator (CFTR) maturation and stability in different ways. A highly conserved hydrophobic patch (region I) formed by residues 1413-1416 (FLVI) was found to be crucial for the stability of the mature protein. Nascent chain stability was severely decreased by shortening the protein by 81 amino acids (1400X). This accelerated degradation was sensitive to proteasome inhibitors but not influenced by brefeldin A, indicating that it occurred at the endoplasmic reticulum. The five residues at positions 1400 to 1404 (region II) normally maintain nascent CFTR stability in a positional rather than a sequence-specific manner. A third modulating region (III) constituted by residues 1390 to 1394 destabilizes the protein. Hence the nascent form regains stability on further truncation back to residues 1390 or 1380, permitting some degree of maturation and a low level of cyclic AMP-stimulated chloride channel activity at the cell surface. Thus while not absolutely essential, the C-terminal domain strongly modulates the biogenesis and maturation of CFTR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11022033     DOI: 10.1074/jbc.M003672200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  The H-loop in the second nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator is required for efficient chloride channel closing.

Authors:  Monika Kloch; Michał Milewski; Ewa Nurowska; Beata Dworakowska; Garry R Cutting; Krzysztof Dołowy
Journal:  Cell Physiol Biochem       Date:  2010-01-12

2.  Structural mechanisms for defective CFTR gating caused by the Q1412X mutation, a severe Class VI pathogenic mutation in cystic fibrosis.

Authors:  Jiunn-Tyng Yeh; Ying-Chun Yu; Tzyh-Chang Hwang
Journal:  J Physiol       Date:  2018-12-02       Impact factor: 5.182

3.  A highly conserved motif at the COOH terminus dictates endoplasmic reticulum exit and cell surface expression of NKCC2.

Authors:  Nancy Zaarour; Sylvie Demaretz; Nadia Defontaine; David Mordasini; Kamel Laghmani
Journal:  J Biol Chem       Date:  2009-06-17       Impact factor: 5.157

4.  Correctors and Potentiators Rescue Function of the Truncated W1282X-Cystic Fibrosis Transmembrane Regulator (CFTR) Translation Product.

Authors:  Peter M Haggie; Puay-Wah Phuan; Joseph-Anthony Tan; Haijin Xu; Radu G Avramescu; Doranda Perdomo; Lorna Zlock; Dennis W Nielson; Walter E Finkbeiner; Gergely L Lukacs; Alan S Verkman
Journal:  J Biol Chem       Date:  2016-11-28       Impact factor: 5.157

5.  Role of the NH2-terminal membrane spanning domain of multidrug resistance protein 1/ABCC1 in protein processing and trafficking.

Authors:  Christopher J Westlake; Susan P C Cole; Roger G Deeley
Journal:  Mol Biol Cell       Date:  2005-03-16       Impact factor: 4.138

6.  Functional analysis of the C-terminal boundary of the second nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator and structural implications.

Authors:  Martina Gentzsch; Andrei Aleksandrov; Luba Aleksandrov; John R Riordan
Journal:  Biochem J       Date:  2002-09-01       Impact factor: 3.857

7.  Effects of C-terminal deletions on cystic fibrosis transmembrane conductance regulator function in cystic fibrosis airway epithelia.

Authors:  Lynda S Ostedgaard; Christoph Randak; Tatiana Rokhlina; Philip Karp; Daniel Vermeer; Katherine J Ashbourne Excoffon; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

8.  The V510D suppressor mutation stabilizes DeltaF508-CFTR at the cell surface.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  Biochemistry       Date:  2010-08-03       Impact factor: 3.162

9.  Keratin K18 increases cystic fibrosis transmembrane conductance regulator (CFTR) surface expression by binding to its C-terminal hydrophobic patch.

Authors:  Yuanyuan Duan; Ying Sun; Fan Zhang; Wei Kevin Zhang; Dong Wang; Yan Wang; Xu Cao; Wenbao Hu; Changyan Xie; John Cuppoletti; Thomas M Magin; Haixia Wang; Zhenguo Wu; Ning Li; Pingbo Huang
Journal:  J Biol Chem       Date:  2012-10-08       Impact factor: 5.157

Review 10.  Pharmacological approaches for targeting cystic fibrosis nonsense mutations.

Authors:  Jyoti Sharma; Kim M Keeling; Steven M Rowe
Journal:  Eur J Med Chem       Date:  2020-05-21       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.